UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Broadcom
AVGO
$1.85T
| $119M | 0.11% |
8,956,030
+428,670
| +5% | +$5.62M |
|
202
T. Rowe Price
TROW
$23.9B
| $118M | 0.11% |
1,515,027
+112,426
| +8% | +$9.07M |
|
203
Cardinal Health
CAH
$53.9B
| $118M | 0.11% |
1,407,113
-131,406
| -9% | -$11.6M |
|
204
Netflix
NFLX
$299B
| $117M | 0.11% |
12,414,710
-54,880
| -0.4% | -$459K |
|
205
TSMC
TSM
$2.1T
| $116M | 0.11% |
5,118,088
+190,646
| +4% | +$4.55M |
|
206
Labcorp
LH
$25B
| $116M | 0.11% |
1,114,067
-52,447
| -4% | -$5.46M |
|
207
Becton Dickinson
BDX
$45.6B
| $116M | 0.11% |
839,156
-151,931
| -15% | -$21M |
|
|
RTN
208
DELISTED
Raytheon Company
RTN
| $116M | 0.11% |
1,211,509
+70,905
| +6% | +$7.43M |
|
|
HES
209
DELISTED
Hess
HES
| $115M | 0.11% |
1,721,471
-75,058
| -4% | -$5.32M |
|
210
Deere & Co
DE
$160B
| $115M | 0.11% |
1,180,327
+20,461
| +2% | +$1.86M |
|
211
Bread Financial
BFH
$4.37B
| $113M | 0.11% |
485,712
+71,841
| +17% | +$17.2M |
|
212
Digital Realty Trust
DLR
$69.7B
| $113M | 0.11% |
1,694,272
-321,978
| -16% | -$21.2M |
|
213
Exelon
EXC
$47.2B
| $113M | 0.11% |
5,035,220
-97,670
| -2% | -$2.34M |
|
214
Healthpeak Properties
DOC
$15.1B
| $112M | 0.11% |
3,376,505
+170,823
| +5% | +$6.22M |
|
215
Eaton
ETN
$161B
| $110M | 0.11% |
1,636,649
+133,082
| +9% | +$9.39M |
|
216
Humana
HUM
$43.7B
| $110M | 0.11% |
575,412
-230
| -0% | -$42.7K |
|
217
Bank of Montreal
BMO
$126B
| $110M | 0.1% |
1,847,994
-763
| -0% | -$47.9K |
|
218
F5
FFIV
$22.9B
| $109M | 0.1% |
905,419
+62,462
| +7% | +$7.68M |
|
219
Johnson Controls International
JCI
$88.8B
| $108M | 0.1% |
2,078,148
-16,513
| -0.8% | -$884K |
|
220
Paychex
PAYX
$41.6B
| $108M | 0.1% |
2,298,511
+64,897
| +3% | +$3.17M |
|
|
PCP
221
DELISTED
PRECISION CASTPARTS CORP
PCP
| $107M | 0.1% |
536,387
+87,755
| +20% | +$18.4M |
|
222
Ralph Lauren
RL
$22.6B
| $107M | 0.1% |
807,752
-378,878
| -32% | -$51.2M |
|
|
CTRX
223
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $107M | 0.1% |
1,745,453
-26,196
| -1% | -$1.57M |
|
224
Corning
GLW
$119B
| $106M | 0.1% |
5,396,350
-800,099
| -13% | -$17.1M |
|
225
State Street
STT
$50.6B
| $106M | 0.1% |
1,380,232
+7,002
| +0.5% | +$545K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.